Richard Paul, MD

Richard Paul is a licensed MD with extensive experience in drug development, drug safety, global regulatory affairs, and translational clinical research. He has held leadership positions in clinical research, regulatory, and medical safety departments with several major pharmaceutical companies including Pfizer, Schering Plough, Ergo Science, Grünenthal USA, and Shionogi USA. He also served as Global Head of Regulatory Affairs for ICON and as a Sr. Medical Monitor for Synteract for many years. His experience spans medical safety, medical monitoring, drug development, and regulatory strategy. He has worked with numerous multi-divisional FDA submissions as well as with international competent regulatory authorities.